Neuroprotective Agents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Neuroprotective Agents Market is Segmented by Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis), Route of Administration (Oral, Topical, Epidural, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Neuroprotective Agents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Neuroprotective Agents Industry Overview

The Neuroprotective Agents Market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Merck KGaA, Novartis Pharmaceuticals Corporation, Teva Pharmaceutical Industries Ltd., Genervon Biopharmaceuticals, LLC., Neuren Pharmaceuticals, Pfizer Inc, GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals PLC.

Neuroprotective Agents Market Leaders

  1. Merck KGaA

  2. Novartis Pharmaceuticals Corporation

  3. Teva Pharmaceutical Industries Ltd.

  4. Pfizer Inc

  5. GlaxoSmithKline plc.

  6. *Disclaimer: Major Players sorted in no particular order
Merck KGaA, Novartis Pharmaceuticals Corporation, Teva Pharmaceutical Industries Ltd., Pfizer Inc, GlaxoSmithKline plc.

Global Neuroprotective Agents Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?